Enanta Pharmaceuticals (ENTA) Tax Provisions (2014 - 2026)
Enanta Pharmaceuticals (ENTA) reported Tax Provisions of $7000.0 for Q1 2026, up 100.54% on a YoY basis from $3490.6 in Q1 2025, and down 70.83% quarter-over-quarter from $24000.0 in Q4 2025.
Enanta Pharmaceuticals (ENTA) Tax Provisions (2014 - 2026) Analysis & Trends
Enanta Pharmaceuticals has reported Tax Provisions for 13 years, with the latest figure at $7000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 100.54% year-over-year to $7000.0; the trailing twelve-month figure through Mar 2026 stood at $92000.0 (up 103.44% YoY), and the FY2025 full-year result was -$1.7 million, up 14.26% from the prior year.
- Tax Provisions for Q1 2026 stood at $7000.0, down from $24000.0 in the prior quarter.
- The five-year high for Tax Provisions was $4.2 million in Q2 2023, with the low at -$1.4 million in Q3 2023.
- Historically, Tax Provisions has averaged -$73562.5 across 5 years, with a median of -$198500.0 in 2022.
- The largest YoY upside for Tax Provisions was 1044.3% in 2023 against a maximum downside of 10171.43% in 2023.
- Enanta Pharmaceuticals' Tax Provisions stood at -$34000.0 in 2022, then tumbled by 1729.41% to -$622000.0 in 2023, then jumped by 33.12% to -$416000.0 in 2024, then jumped by 105.77% to $24000.0 in 2025, then slumped by 70.83% to $7000.0 in 2026.
- The last three Tax Provisions figures came in at $7000.0 (Q1 2026), $24000.0 (Q4 2025), and $32000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 365.48 Mn | 201.71 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | -1.31 Mn |
| Dec 31, 2024 | -416,000.00 |
| Sep 30, 2024 | -556,000.00 |
| Jun 30, 2024 | -395,000.00 |
| Mar 31, 2024 | -363,000.00 |
| Dec 31, 2023 | -622,000.00 |
| Sep 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 44,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | -447,000.00 |
| Dec 31, 2021 | -36,000.00 |
| Sep 30, 2021 | 48.51 Mn |
| Jun 30, 2021 | -9.38 Mn |
| Mar 31, 2021 | 7.11 Mn |